Adenosine Phosphate

Adenosine Phosphate

SCHEMBL7672973

Nc1ncnc2c1ncn2[C@@H]1O[C@H](COP(=O)(O)O)[C@@H](O)[C@H]1O.c1cncnc1

nearest known ligand 0.89

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
P2RY1 P47900 5/20 0.89
P2RY2 P41231 3/20 0.89
SRC P12931 2/20 0.89
SMN1; SMN2 Q16637 2/20 0.89
TRPM2 O94759 2/20 0.89
TAS1R3 Q7RTX0 2/20 0.89
TAS1R1 Q7RTX1 2/20 0.89
DNPH1 O43598 1/20 0.89
PRKAB2 O43741 1/20 0.89
LDHA P00338 1/20 0.89
ADRB2 P07550 1/20 0.89
FBP1 P09467 1/20 0.89
ADORA1 P30542 1/20 0.89
PRKAG1 P54619 1/20 0.89
PRKAA2 P54646 1/20 0.89
PDE4D Q08499 1/20 0.89
KCNH2 Q12809 1/20 0.89
PRKAA1 Q13131 1/20 0.89
PDE3A Q14432 1/20 0.89
P2RY11 Q96G91 1/20 0.89

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Adenosine Phosphate SCHEMBL14478782 0.94 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL13374692 0.94 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL144997 0.94 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL1338615 0.94 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL8572634 0.94 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL19420134 0.94 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL13170051 0.94 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL11977309 0.94 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL132458 0.94 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2
Adenosine Phosphate SCHEMBL20277555 0.94 P2RY1 (1.00) P2RY1P2RY2SRCSMN1; SMN2TRPM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6500652-B2 OLIGONUCLEOTIDE OF >/=4 NUCLEOTIDES THAT HAS A VIRAL NUCLEIC ACID SEQUENCE WHICH INCLUDES THE INITIATION NUCLEOTIDE ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. 2002-12-31 US disclosed
US-20020103143-A1 USE OF NUCLEIC ACID MOLECULES AS ANTIVIRAL AGENTS INDIANA UNIVERSITY RESEARCH AND TECHNOLOGY CORP. 2002-08-01 US disclosed
WO-1999049085-A9 USE OF A VIRAL POLYMERASE TO AMPLIFY NUCLEIC ACIDS ADVANCED RES & TECH INST (US) 1999-11-25 WO disclosed
WO-1999049085-A1 USE OF A VIRAL POLYMERASE TO AMPLIFY NUCLEIC ACIDS ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. (US) 1999-09-30 WO disclosed
WO-1999049031-A1 USE OF NUCLEIC ACID MOLECULES AS ANTIVIRAL AGENTS ADVANCED RESEARCH AND TECHNOLOGY INSTITUTE, INC. (US) 1999-09-30 WO disclosed